Bulgarian venture capital fund LAUNCHub Ventures said on 19 February that it led a $4.2 million
(3.9 million euro) seed funding round of UK-based biotech startup GlycanAge, alongside UK deep-
tech fund Kadmos Capital.
GlycanAge will use the fresh funding to strategically shift from the longevity space to the broader
diagnostics market, advancing its mission to redefine personalised preventative healthcare,
LAUNCHub Ventures told SeeNews in an emailed statement, without disclosing the size of its
investment. The financial injection will also allow GlycanAge to establish a clear regulatory strategy and product pipeline in order to develop disease-specific prognostic biomarkers.
The startup is additionally backed by a $140,000 grant from Emirati state-owned fund Mubadala’s
accelerator programme HUB71 and $220,000 from an EU artificial intelligence (AI) grant, aiming to
bridge the gap between diagnostics and AI.
https://seenews.com/news/bulgarias-launchub-ventures-invests-in-glycanage-848888
Don't miss out on the excitement! Reserve your spot at one of our upcoming events:
SCALE UP WITH WOLVES AND EUROPEAN CVC AWARDS
26 March 2024, Spielfeld Digital Hub, Germany + online
WOLVES SUMMIT CEE
8-9 May 2024, Copernicus Science Centre, Warsaw, Poland + online